These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 31621042)
1. Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens. Yeo KK; Margol AS; Kennedy RJ; Hung L; Robison NJ; Dhall G; Asgharzadeh S J Neurooncol; 2019 Nov; 145(2):375-383. PubMed ID: 31621042 [TBL] [Abstract][Full Text] [Related]
2. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial. Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813 [TBL] [Abstract][Full Text] [Related]
3. Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial. Robinson GW; Rudneva VA; Buchhalter I; Billups CA; Waszak SM; Smith KS; Bowers DC; Bendel A; Fisher PG; Partap S; Crawford JR; Hassall T; Indelicato DJ; Boop F; Klimo P; Sabin ND; Patay Z; Merchant TE; Stewart CF; Orr BA; Korbel JO; Jones DTW; Sharma T; Lichter P; Kool M; Korshunov A; Pfister SM; Gilbertson RJ; Sanders RP; Onar-Thomas A; Ellison DW; Gajjar A; Northcott PA Lancet Oncol; 2018 Jun; 19(6):768-784. PubMed ID: 29778738 [TBL] [Abstract][Full Text] [Related]
4. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups. Carrie C; Kieffer V; Figarella-Branger D; Masliah-Planchon J; Bolle S; Bernier V; Laprie A; Supiot S; Leseur J; Habrand JL; Alapetite C; Kerr C; Dufour C; Claude L; Chapet S; Huchet A; Bondiau PY; Escande A; Truc G; Nguyen TD; Pasteuris C; Vigneron C; Muracciole X; Bourdeaut F; Appay R; Dubray B; Colin C; Ferlay C; Dussart S; Chabaud S; Padovani L; ; Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1204-1217. PubMed ID: 32768563 [TBL] [Abstract][Full Text] [Related]
5. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study. Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823 [TBL] [Abstract][Full Text] [Related]
6. Molecular Classification Improves Therapeutic Options for Infants and Young Children With Medulloblastoma. Bagchi A; Dhanda SK; Dunphy P; Sioson E; Robinson GW J Natl Compr Canc Netw; 2023 Aug; 21(10):1097-1105. PubMed ID: 37643637 [TBL] [Abstract][Full Text] [Related]
7. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy. Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704 [TBL] [Abstract][Full Text] [Related]
8. Rapid diagnosis of medulloblastoma molecular subgroups. Schwalbe EC; Lindsey JC; Straughton D; Hogg TL; Cole M; Megahed H; Ryan SL; Lusher ME; Taylor MD; Gilbertson RJ; Ellison DW; Bailey S; Clifford SC Clin Cancer Res; 2011 Apr; 17(7):1883-94. PubMed ID: 21325292 [TBL] [Abstract][Full Text] [Related]
9. Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups. Tonn S; Korshunov A; Obrecht D; Sill M; Spohn M; von Hoff K; Milde T; Pietsch T; Goschzik T; Bison B; Juhnke BO; Struve N; Sturm D; Sahm F; Bockmayr M; Friedrich C; von Bueren AO; Gerber NU; Benesch M; Jones DTW; Kool M; Wefers AK; Schüller U; Pfister SM; Rutkowski S; Mynarek M Neuro Oncol; 2023 Aug; 25(8):1518-1529. PubMed ID: 36715306 [TBL] [Abstract][Full Text] [Related]
10. [Molecular subgrouping and characterization analysis of medulloblastomas in a cohort of Japanese patients]. Wataya T; Hamasaki M; Taylor MD No Shinkei Geka; 2015 Feb; 43(2):117-25. PubMed ID: 25672552 [TBL] [Abstract][Full Text] [Related]
11. Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. Erker C; Mynarek M; Bailey S; Mazewski CM; Baroni L; Massimino M; Hukin J; Aguilera D; Cappellano AM; Ramaswamy V; Lassaletta A; Perreault S; Kline CN; Rajagopal R; Michaiel G; Zapotocky M; Santa-Maria Lopez V; La Madrid AM; Cacciotti C; Sandler ES; Hoffman LM; Klawinski D; Khan S; Salloum R; Hoppmann AL; Larouche V; Dorris K; Toledano H; Gilheeney SW; Abdelbaki MS; Wilson B; Tsang DS; Knipstein J; Oren MY; Shah S; Murray JC; Ginn KF; Wang ZJ; Fleischhack G; Obrecht D; Tonn S; Harrod VL; Matheson K; Crooks B; Strother DR; Cohen KJ; Hansford JR; Mueller S; Margol A; Gajjar A; Dhall G; Finlay JL; Northcott PA; Rutkowski S; Clifford SC; Robinson G; Bouffet E; Lafay-Cousin L J Clin Oncol; 2023 Apr; 41(10):1921-1932. PubMed ID: 36548930 [TBL] [Abstract][Full Text] [Related]
12. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma. Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958 [TBL] [Abstract][Full Text] [Related]